Thursday, November 5, 2026

Funding · Chapel Hill, NC

Carolina Angel Network backs AI biotech Network Bio

UNC-Chapel Hill's angel network disclosed its stake in the alumni-led startup and is piloting a fellowship to help researchers spin out companies.

·

Carolina Angel Network backs AI biotech Network Bio

The Carolina Angel Network, the angel investing network of the University of North Carolina at Chapel Hill, announced on Oct. 23, 2026, that it invested earlier this year in Network Bio, a biotechnology company building disease-specific AI models from human biological data. The network invested alongside a syndicate of institutional investors that includes Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund and JSL Health Capital.

Network Bio is led by CEO and co-founder Asad Ahmad, Ph.D., a graduate of the Lampe Joint Department of Biomedical Engineering at UNC-Chapel Hill and NC State University. The company emerged from stealth in August 2026 with $50 million in financing. According to the announcement, it has built a research network of U.S. academic biobanks, including Mass General Brigham, the University of Pennsylvania and the University of Colorado Anschutz, and has signed a co-development and licensing agreement valued at more than $30 million with a Fortune 100 healthcare company.

"Having the Carolina Angel Network join this round means a great deal to me personally," Ahmad said in the release. "With their support, we are turning decades of banked patient tissue at leading academic medical centers into AI models that can detect disease earlier and match patients to the right therapy."

Alongside the investment, the network is piloting an Innovation Fellowship with the Lampe Joint Department of Biomedical Engineering. The program gives a postdoctoral researcher one year to explore building a company around university intellectual property, and fellows ready to spin out in year two receive a $100,000 early investment. Founded in 2016, the Carolina Angel Network says it has invested more than $34 million across 41 companies.

Share this storyXLinkedInFacebookWhatsAppEmail

About this story

By Sotwire Desk. Written by Sotwire Desk from the sources below. Not a company attestation.

Desk reportedSotwire Desk. Written by a named Sotwire editor from the sources cited below. Not a company attestation. Sotwire corrects errors publicly.

Key facts

Company
Carolina Angel Network
Place
Chapel Hill, NC
Section
Funding
Announced
Record
Desk reported
Company source
Sotwire Desk
Investor
Carolina Angel Network, UNC-Chapel Hill
Portfolio company
Network Bio, AI biotech
Network Bio CEO
Asad Ahmad, Ph.D., co-founder
Network Bio financing
$50 million, announced August 2026
Co-investors
Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL Health Capital
New program
Innovation Fellowship pilot with the Lampe Joint Department of Biomedical Engineering
Fellowship investment
$100,000 for fellows ready to spin out in year two
Network track record
More than $34 million across 41 companies since 2016

Key events

  1. Network Bio emerged from stealth with $50 million in financing
  2. Carolina Angel Network announced its investment and fellowship pilot

Sources

  1. Carolina Angel Network Invests in Network Bio, AI Biotech Founded by Lampe Joint BME Alumnus · Carolina Angel Network · accessed 2026-10-28
  2. Cary CEO secures $50M to grow AI-powered biotech that's already inked big-name partners · Triangle Business Journal · accessed 2026-10-28

North Carolina business, in one useful email.

Get launches, hires, funding, and project wins from across the state, with the Triangle at the center. Each story names the company source who stood behind it.

By subscribing, you agree to receive the Sotwire newsletter. We will not sell your email address. Newsletter details.